2021 annual financial data
TransCode Therapeutics, Inc. 2021 Operating margin
TransCode Therapeutics, Inc. 2021 operating margin with verified reported value…
Direct answer
Operating margin was Not calculable.
Operating income was -6,151,135 USD and net income was -6,843,399 USD.
Operating cash flow was -5,266,885 USD.
Get free TransCode Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,151,135 USD
- Net income
- -6,843,399 USD
- Operating cash flow
- -5,266,885 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all TransCode Therapeutics, Inc. financial years